Skip to content

A study on the diagnostic value of ultramicrofluidic imaging for distinguishing between benign and malignant breast tumours

A study on the diagnostic value of ultramicrofluidic imaging for distinguishing between benign and malignant breast tumours

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500104530
Enrollment
Unknown
Registered
2025-06-18
Start date
2025-06-20
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast nodule diagnosed by ultrasound as ACR BI-RADS category 3-5

Interventions

Gold Standard:The final diagnosis is determined by the presence of pathological findings from surgical excision or a puncture biopsy.
Index test:Two-dimensional ultrasound features of breast nodules: shape (regular, irregular), aspect ratio (parallel, non-parallel), margins (clear, unclear), calcification (none, present), lymphadeno

Sponsors

the First Affiliated Hospital of Shan Tou University Medical College
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1.Patients with an ultrasound diagnosis of an ACR BI-RADS category 3-5 breast nodule;

Exclusion criteria

Exclusion criteria: 1.The patient has undergone one or more of the following treatments: radiation therapy, chemotherapy, or surgical removal of the ipsilateral breast within a two-year period. 2.The patient is incapable of cooperating in the completion of an ultrasound or pathological diagnosis.

Design outcomes

Primary

MeasureTime frame
Pathological diagnostic findings;

Secondary

MeasureTime frame
Lymph node metastasis status;

Countries

China

Contacts

Public ContactLin Teng

The First Affiliated Hospital of Shantou University Medical College

13502952420@163.com+86 754 88905199

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026